HPTN
(MedicalXpress) ICAP’s Wafaa El-Sadr on HPTN 083 Injectable PrEP Results
The HIV Prevention Trials Network (HPTN) announced results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to daily oral tenofovir/emtricitabine (TDF/FTC)...
(Medical Xpress) ICAP’s Wafaa El-Sadr on HPTN 071 (PopART) Results
HPTN 071 (PopART) examined the impact of a package of HIV prevention interventions, including universal testing and treatment, on community-level HIV incidence amongst more than one million people living in 21 urban and peri-urban communities in Zambia and South...
ICAP to Test New Combinations of Antibodies for HIV Prevention
ICAP at Columbia University is playing a key role in testing the feasibility of a potential breakthrough in the global effort to stop HIV transmission. The Harlem Prevention Center, one of ICAP’s two clinical research centers in New York, is participating in a...